Dr Richard Simcock | GMC# 4030421

  • Brighton and Sussex University Hospitals NHS Trust
  • Consultant Clinical Oncologist

Archived Declarations


Oct. 1, 2019

Benefits received from pharmaceutical companies


Company Reason for receipt of fees Total amount received
Novartis Conference Attendance (ESMO 2019) 3

Oct. 12, 2018

Benefits received from pharmaceutical companies


Company Reason for receipt of fees Total amount received
Novartis Advisory Board 2
Genomic Health Advisory Board 2

Feb. 27, 2017

Benefits received from pharmaceutical companies


Company Reason for receipt of fees Total amount received
Roche Amercian Society of Clinical Oncology online conference pass under £100
Eisai Speaker's Fee 2

Other sources of income or benefits from other organisations relevant to medical practice


Company Reason for receipt of fees Total amount received
Parliamentary and Health Service Ombudsman Medical Advisor / Case Reviews 2
20:20 Health Consultancy Contribution to strategy and insight for input to CR:UK work on MDT working 2